Compare ARCT & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARCT | ANIK |
|---|---|---|
| Founded | 2013 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.9M | 192.4M |
| IPO Year | 2019 | 1996 |
| Metric | ARCT | ANIK |
|---|---|---|
| Price | $6.87 | $14.26 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 1 |
| Target Price | ★ $27.70 | $17.00 |
| AVG Volume (30 Days) | ★ 460.5K | 131.9K |
| Earning Date | 03-03-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 20.00 | ★ 80.16 |
| EPS | N/A | ★ N/A |
| Revenue | $82,031,000.00 | ★ $112,819,000.00 |
| Revenue This Year | N/A | $5.98 |
| Revenue Next Year | N/A | $7.42 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.85 | $7.90 |
| 52 Week High | $24.14 | $15.79 |
| Indicator | ARCT | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 44.29 | 65.05 |
| Support Level | $5.93 | $9.08 |
| Resistance Level | $7.88 | $15.01 |
| Average True Range (ATR) | 0.39 | 0.51 |
| MACD | -0.08 | -0.16 |
| Stochastic Oscillator | 34.93 | 42.75 |
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.